Advocacy Alert: Contact Your Rep Regarding Opioid Settlement Funds
Advocacy Advocacy Alerts Find Your Representatives State FAQs Legal Repository Contact Us Advocacy Alert: Contact Your Rep Regarding Opioid Settlement Funds April 28, 2022 via Shatterproof Opioid-involved overdoses have killed more than half a million people...
Advocacy Alert: CDC’s Draft Clinical Practice Guideline for Prescribing Opioids Open for Public Comment
Advocacy Advocacy Alerts Find Your Representatives State FAQs Legal Repository Contact Us Advocacy Alert: CDC’s Draft Clinical Practice Guideline for Prescribing Opioids Open for Public Comment February 17, 2022 via SAMHSA (Substance Abuse and Mental Health...
Advocacy Alert: Statement from SAMHSA Leader on FDA’s Drug Safety Alert on Buprenorphine and Risk for Tooth Decay
Advocacy Advocacy Alerts Find Your Representatives State FAQs Legal Repository Contact Us Advocacy Alert: Statement from SAMHSA Leader on FDA’s Drug Safety Alert on Buprenorphine and Risk for Tooth Decay January 20, 2022 via SAMHSA On January 13, 2022, Miriam...
Advocacy Alert: 2021 Year End Advocacy Update
Advocacy Advocacy Alerts Find Your Representatives State FAQs Legal Repository Contact Us Advocacy Alert: 2021 Year End Advocacy Update December 23, 2021 Did you know that one of the many benefits BHAP members get is regular access to our advocate in Washington, DC,...
A national membership association that provides education and advocacy for those in the behavioral health and addiction treatment industries.
We are the leading and unifying voice of addiction-focused treatment programs.
